Cognitive reserve influences age of onset, speed of progression, and clinical manifestations of Alzheimer’s disease. We investigated whether cognitive reserve interacts with clinical and neuropsychological parameters in mild cognitive impairment (MCI).
Methods:
In this cross-sectional study, we recruited 273 people (70.6 ± 10.1 years, 54.6% women) suffering from subjective memory complaints (n = 65), MCI (n = 121), or dementia (n = 87). Patients underwent neuropsychological evaluation, laboratory testing, and brain imaging. Additionally, we obtained information on years of education and help-seeking motivation.
Results:
MCI patients with a university degree were significantly older than those without (71.6 ± 9.6 vs. 66.9 ± 10.3, p = 0.02). University-educated MCI patients demonstrated superior performance in verbal fluency. Intrinsic help-seeking motivation (self-referral) was associated with higher cognitive reserve. Female MCI patients presented with greater intrinsic motivation.
Conclusion:
Cognitive reserve modulates clinical and neuropsychological measures in patients with MCI.
ChengST. Cognitive reserve and the prevention of dementia: the role of physical and cognitive activities. Curr Psychiatry Rep2016; 18: 85.
2.
FranzmeierNGottlerJGrimmerT, et al. Resting-state connectivity of the left frontal cortex to the default mode and dorsal attention network supports reserve in mild cognitive impairment. Front Aging Neurosci2017; 7: 264.
3.
FranzmeierNHartmannJCTaylorANW, et al. Left frontal hub connectivity during memory performance supports reserve in aging and mild cognitive impairment. J Alzheimers Dis2017; 59: 1381–1392.
4.
SternY. Cognitive reserve in ageing and Alzheimer’s disease. Lancet2012; 11: 1006–1012.
5.
PettigrewCSoldanA. Defining cognitive reserve and implications for cognitive aging. Curr Neurol Neurosci Rep2019; 19: 1.
6.
RussT. Intelligence, cognitive reserve, and dementia - time for intervention?JAMA Network Open2018; 1: e181724.
7.
KukullWAHigdonRBowenJD, et al. Dementia and Alzheimer disease incidence: a prospective cohort study. Arch Neurol2002; 59: 1737–1746.
8.
LindsayJLaurinDVerreaultR, et al. Risk factors for Alzheimer’s disease: a prospective analysis from the Canadian Study of health and aging. Am J Epidemiol2002; 156: 445–453.
9.
RoeCFaganAMGrantEA, et al. Cerebrospinal fluid biomarkers, education, brain volume, and future cognition. Arch Neurol2011; 68: 1145–1151.
10.
SoldanAPettigrewCLuY, et al. Relationship of medial temporal lobe atrophy APOE genotype, and cognitive reserve in preclinical Alzheimer’s disease. Human Brain Mapping2015; 36: 2826–2841.
11.
BessiVMazzeoSPadiglioniS, et al. From subjective cognitive decline to Alzheimer’s disease: the predictive role of neuropsychological assessment, personality traits, and cognitive reserve. A 7-year follow-up study. J Alzheimers Dis2018; 63: 1523–1535.
12.
MazzeoSPadiglioniSBagnoliS, et al. The dual role of cognitive reserve in subjective cognitive decline and mild cognitive impairment: a 7-year follow-up study. J Neurol2019; 266(2): 487–497.
13.
ReijsBVosSJBSoininenH, et al. Association between later life lifestyle factors and Alzheimer’s disease biomarkers in non-demented individuals: a longitudinal descriptive cohort study. J Alzheimers Dis2017; 60: 1387–1395.
14.
BettcherBMMungasDPatelN, et al. Neuroanatomical substrates of executive functions: beyond prefrontal structures. Neuropsychologia2016; 85: 100–109.
15.
HaussmannRMayer-PelinskiRBorchardtM, et al. Extrinsic and intrinsic help-seeking motivation in the assessment of cognitive decline. Am J Alzheimers Dis Other Demen2018; 33: 215–220.
16.
CutlerSJ. Worries about getting Alzheimer’s: who’s concerned?Am J Alzheimers Dis Other Demen2015; 30(6): 591–598.
17.
AbdulrabKHeunR. Subjective memory impairment. A review of its definitions indicates the need for a comprehensive set of standardised and validated criteria. Eur Psychiatry2008; 23: 321–330.
18.
PetersenR. Mild cognitive impairment as a diagnostic entity. J Intern Med2004; 256: 183–194.
19.
AlbertMSDeKoskySTDicksonD, et al. The diagnosis of mild cognitive impairment due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement2011; 7: 270–279.
20.
McKhannGDrachmanDFolsteinM, et al. Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s Disease. Neurology1984; 34: 939–944.
21.
NeubauerAGrabnerRHFreudenthalerHH, et al. Intelligence and individual differences in becoming neurally efficient. Acta Psychol (Amst)2004; 116: 55–74.
22.
KesslerJFastKMielkeR. Premorbid intelligence diagnosis with the MWT-B (Multiple Choice Word Test-B) in patients with Alzheimer disease. Nervenarzt1995; 66: 696–702.
23.
MengXD’ArcyC. Education and dementia in the context of the cognitive reserve hypothesis: a systematic review with meta-analyses and qualitative analyses. PLoS One2012; 7(6): e38268.
24.
SoldanAPettigrewCCaiQ, et al. Cognitive reserve and long-term change in cognition in aging and preclinical Alzheimer’s disease. Neurobiol Aging2017; 60: 164–172.
25.
Dos SantosVThomannPAWustenbergT, et al. Morphological cerebral correlates of CERAD test performance in mild cognitive impairment and Alzheimer’s disease. J Alzheimers Dis2011; 23: 411–420.
